trending Market Intelligence /marketintelligence/en/news-insights/trending/6ib-u8zv2uvmjgn3qomklg2 content esgSubNav
In This List

ContraFect prices $10M common stock offering

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


ContraFect prices $10M common stock offering

ContraFect Corp. priced its offering of 5 million common shares at a $2 per share to raise $10 million in gross proceeds.

The Yonkers, N.Y.-based developer of drugs also granted the underwriters an option to buy up to an additional 750,000 shares.

The offering is expected to close July 31.

Piper Jaffray & Co. and William Blair & Co. LLC are acting as joint book-running managers, and Chardan is acting as the lead manager for the offering.